An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Silk Road Medical, Inc. (Nasdaq: SILK) will present at the BofA Securities 2024 Healthcare Conference on May 14, 2024, at 3:40 p.m. Pacific Time. The presentation aims to showcase the company's efforts in reducing the risk of stroke. Interested parties can access the webcast on the company's website.
Silk Road Medical, Inc. (Nasdaq: SILK) presenterà alla Conferenza Sanitaria di BofA Securities 2024 il 14 maggio 2024, alle 15:40, ora del Pacifico. La presentazione mira a mostrare gli sforzi dell'azienda nella riduzione del rischio di ictus. Le parti interessate possono seguire il webcast sul sito web dell'azienda.
Silk Road Medical, Inc. (Nasdaq: SILK) participará en la Conferencia Sanitaria de BofA Securities 2024 el 14 de mayo de 2024, a las 3:40 p.m., hora del Pacífico. La presentación tiene como objetivo exponer los esfuerzos de la compañía para reducir el riesgo de accidente cerebrovascular. Las partes interesadas pueden acceder a la transmisión por internet en el sitio web de la empresa.
실크 로드 메디컬, 인크.(Nasdaq: SILK)는 2024년 5월 14일 오후 3시 40분 태평양 표준시에 BofA 증권 2024 헬스케어 컨퍼런스에서 발표할 예정입니다. 이 발표는 회사가 뇌졸중 위험을 줄이기 위한 노력을 보여주기 위한 것입니다. 관심 있는 당사자들은 회사 웹사이트에서 웹캐스트를 볼 수 있습니다.
Silk Road Medical, Inc. (Nasdaq: SILK) présentera lors de la Conférence Santé de BofA Securities 2024 le 14 mai 2024 à 15h40, heure du Pacifique. La présentation vise à mettre en avant les efforts de la société pour réduire le risque d'accident vasculaire cérébral. Les parties intéressées peuvent accéder à la diffusion Web sur le site de l'entreprise.
Silk Road Medical, Inc. (Nasdaq: SILK) wird am 14. Mai 2024 um 15:40 Uhr pazifischer Zeit auf der BofA Securities Gesundheitskonferenz 2024 präsentieren. Die Präsentation zielt darauf ab, die Bemühungen des Unternehmens zur Senkung des Schlaganfallrisikos darzulegen. Interessierte Parteien können die Webübertragung auf der Website des Unternehmens abrufen.
Positive
None.
Negative
None.
SUNNYVALE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2024 Healthcare Conference.
Management is scheduled to present on Tuesday, May 14, 2024, at 3:40 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.
About Silk Road Medical Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on X, LinkedIn and Facebook.
When will Silk Road Medical present at the BofA Securities 2024 Healthcare Conference?
Silk Road Medical will present on May 14, 2024, at 3:40 p.m. Pacific Time.
What is the focus of Silk Road Medical?
Silk Road Medical focuses on reducing the risk of stroke.
Where can interested parties watch the presentation?
Interested parties can access a live and archived webcast on the 'Investors' section of Silk Road Medical's website at: https://investors.silkroadmed.com/.
silk road medical, inc. is a privately held company located in sunnyvale, california, dedicated to preventing the devastating burden of stroke through surgical innovation. the company develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies. by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with carotid artery disease. our history is one of deep collaboration with vascular specialists and our future will be guided by continuous learning, observation and improvement. for more information on the company, visit our website at http://silkroadmed.com/. the transcarotid artery revascularization (tcar) procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. th
